Profile | GDS4284 / 228620_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 566.685 | 66 |
GSM687648 | Patient 402 control | 447.094 | 62 |
GSM687653 | Patient 403 control | 633.283 | 68 |
GSM687658 | Patient 404 control | 866.263 | 72 |
GSM687663 | Patient 411 control | 639.556 | 67 |
GSM687668 | Patient 422 control | 431.43 | 62 |
GSM687673 | Patient 424 control | 540.582 | 64 |
GSM687678 | Patient 425 control | 468.23 | 62 |
GSM687683 | Patient 427 control | 468.478 | 61 |
GSM687688 | Patient 428 control | 682.593 | 68 |
GSM687695 | Patient 441 control | 498.813 | 61 |
GSM687699 | Patient 443 control | 781.15 | 70 |
GSM687704 | Patient 444 control | 502.406 | 64 |
GSM687707 | Patient 448 control | 821.461 | 71 |
GSM687712 | Patient 449 control | 270.324 | 53 |
GSM687719 | Patient 450 control | 407.291 | 59 |
GSM687724 | Patient 451 control | 332.749 | 57 |
GSM687728 | Patient 452 control | 845.235 | 72 |
GSM687646 | Patient 401 treated 24h | 531.342 | 64 |
GSM687649 | Patient 402 treated 24h | 647.339 | 67 |
GSM687665 | Patient 411 treated 24h | 691.673 | 68 |
GSM687651 | Patient 402 treated 4 weeks | 555.441 | 64 |
GSM687667 | Patient 411 treated 4 weeks | 829.068 | 71 |
GSM687670 | Patient 422 treated 24h | 484.589 | 62 |
GSM687671 | Patient 422 treated 4 weeks | 470.016 | 62 |
GSM687654 | Patient 403 treated 24h | 731.568 | 70 |
GSM687675 | Patient 424 treated 24h | 588.209 | 65 |
GSM687685 | Patient 427 treated 24h | 489.206 | 63 |
GSM687656 | Patient 403 treated 4 weeks | 570.528 | 66 |
GSM687677 | Patient 424 treated 4 weeks | 427.544 | 61 |
GSM687687 | Patient 427 treated 4 weeks | 554.564 | 65 |
GSM687692 | Patient 428 treated 4h | 848.851 | 71 |
GSM687716 | Patient 449 treated 4h | 237.675 | 52 |
GSM687722 | Patient 450 treated 4h | 471.786 | 62 |
GSM687680 | Patient 425 treated 24h | 552.889 | 65 |
GSM687690 | Patient 428 treated 24h | 852.524 | 72 |
GSM687700 | Patient 443 treated 24h | 639.269 | 65 |
GSM687705 | Patient 444 treated 24h | 561.999 | 66 |
GSM687714 | Patient 449 treated 24h | 350.792 | 59 |
GSM687721 | Patient 450 treated 24h | 457.442 | 61 |
GSM687682 | Patient 425 treated 4 weeks | 496.222 | 64 |
GSM687694 | Patient 428 treated 4 weeks | 650.787 | 67 |
GSM687702 | Patient 443 treated 4 weeks | 788.085 | 70 |
GSM687718 | Patient 449 treated 4 weeks | 190.19 | 47 |
GSM687723 | Patient 450 treated 4 weeks | 490.043 | 63 |
GSM687661 | Patient 404 treated 4h | 881.385 | 72 |
GSM687710 | Patient 448 treated 4h | 721.761 | 70 |
GSM687726 | Patient 451 treated 4h | 461.335 | 61 |
GSM687730 | Patient 452 treated 4h | 42.0321 | 9 |
GSM687660 | Patient 404 treated 24h | 687.264 | 70 |
GSM687697 | Patient 441 treated 24h | 763.497 | 70 |
GSM687709 | Patient 448 treated 24h | 931.175 | 73 |
GSM687725 | Patient 451 treated 24h | 458.517 | 61 |
GSM687729 | Patient 452 treated 24h | 691.369 | 70 |
GSM687727 | Patient 451 treated 4 weeks | 596.3 | 66 |
GSM687731 | Patient 452 treated 4 weeks | 1090.45 | 75 |